Standard InChI: InChI=1S/C24H23BrN6O6S/c1-34-19-9-5-6-10-20(19)37-21-22(31-38(32,33)30-13-17-7-3-2-4-8-17)28-16-29-23(21)35-11-12-36-24-26-14-18(25)15-27-24/h2-10,14-16,30H,11-13H2,1H3,(H,28,29,31)
1.Bolli MH, Boss C, Binkert C, Buchmann S, Bur D, Hess P, Iglarz M, Meyer S, Rein J, Rey M, Treiber A, Clozel M, Fischli W, Weller T.. (2012) The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist., 55 (17):[PMID:22862294][10.1021/jm3009103]
2.Boss C, Bolli MH, Gatfield J.. (2016) From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective., 26 (15):[PMID:27321813][10.1016/j.bmcl.2016.06.014]